U.S. Radiotheranostics Market Size & Outlook, 2026-2033
The radiotheranostics market in the United States is expected to reach a projected revenue of US$ 11,411.2 million by 2033. A compound annual growth rate of 8.6% is expected of the United States radiotheranostics market from 2026 to 2033.
- Pharmaceuticals
- Radiotherapy/Nuclear Medicine
- Radiotheranostics Market Outlook
- Radiotherapy/Nuclear Medicine
Revenue, 2025 (US$M)
$5,522.3
Estimate, 2026 (US$M)
$6,398.0
Forecast, 2033 (US$M)
$11,411.2
CAGR, 2026 - 2033
8.6%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the radiotheranostics market
Every figure cited from GVR research
U.S. radiotheranostics market highlights
- The U.S. radiotheranostics market generated a revenue of USD 5,522.3 million in 2025 and is expected to reach USD 11,411.2 million by 2033.
- The U.S. market is expected to grow at a CAGR of 8.6% from 2026 to 2033.
- In terms of segment, lutetium-177 was the largest revenue generating radioisotope in 2025.
- 18F with Y-90 is the most lucrative radioisotope segment registering the fastest growth during the forecast period.
Radiotheranostics market data book summary
| Market revenue in 2025 | USD 5,522.3 million |
| Market revenue in 2033 | USD 11,411.2 million |
| Growth rate | 8.6% (CAGR from 2026 to 2033) |
| Largest segment | Lutetium-177 |
| Fastest growing segment | 18F with Y-90 |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90 |
Other key industry trends
- In terms of revenue, U.S. accounted for 46.8% of the global radiotheranostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. radiotheranostics market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 405.2 million by 2033.
No credit card required*
Publish Date: Jan 21, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiotheranostics Market Scope
Radiotheranostics Market segmentation & scope
Radiotheranostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| IsoRay | View profile | 51-100 | Richland, Washington, United States, North America | isoray.com/ |
| Point Biopharma | View profile | 101-250 | Indianapolis, Indiana, United States, North America | www.pointbiopharma.com/ |
| Novartis AG | View profile | - | - | - |
| Lantheus Holdings | View profile | 501-1000 | North Billerica, Massachusetts, United States, North America | www.lantheus.com/ |
| Telix Pharmaceuticals | View profile | 251-500 | Melbourne, Victoria, Australia, Oceania | www.telixpharma.com |
| Actinium Pharmaceuticals | View profile | 11-50 | New York, New York, United States, North America | www.actiniumpharmaceuticals.com |
| RadioMedix | View profile | 11-50 | Houston, Texas, United States, North America | radiomedix.com/ |
| SHINE Technologies | View profile | 251-500 | Janesville, Wisconsin, United States, North America | www.shinefusion.com |
| NorthStar Medical Radioisotopes | View profile | 251-500 | Madison, Wisconsin, United States, North America | www.northstarnm.com/ |
U.S. Radiotheranostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Radiotheranostics Market Outlook will help companies and investors design strategic landscapes.
Lutetium-177 was the largest segment with a revenue share of 41.67% in 2025.
Horizon Databook has segmented the U.S. radiotheranostics market based on iodine-131, iodine-123, gallium-68, lutetium-177, 18f with y-90 covering the revenue growth of each sub-segment from 2021 to 2033.
- U.S. Radiotheranostics Market Radioisotope Outlook (Revenue, USD Million , 2021-2033)
- Iodine-131
- Iodine-123
- Gallium-68
- Lutetium-177
- 18F with Y-90
- Others
- U.S. Radiotheranostics Market Approach Outlook (Revenue, USD Million , 2021-2033)
- Targeted Therapeutic
- Targeted Diagnostic
- U.S. Radiotheranostics Market Application Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Non-Oncology
Reasons to subscribe to Radiotheranostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Radiotheranostics Market Outlook databook
- Our clientele includes a mix of Radiotheranostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Radiotheranostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Radiotheranostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Radiotheranostics Market, 2021-2033 (US$M)
U.S. radiotheranostics market statistics, by radioisotope, 2021-2033 (US$M)
